- Anonymous Organization
- From Cayman Islands
- Very responsive
- Project Size Range : Strategic project backed by large scale funding €
- Posted by
Desired outcome
One or more of the molecules Mahuannin B, F, and A from Ephedra Radix plant should be provided in one of the following forms:
1- Synthetically pure molecules
2- Enriched fractions of the plant extract
3- Isolated fraction from plant extract
Details of the Technology Call
The proposed solutions will be evaluated according to the highest possible compound(s) purity and in abscence of Norephedrine, Ephedrine, and Pseudoephedrine as impurities
Technical requirements
Must have:
- Extract obtained from Ephedra Radix and not Ephedra Herba.
- The desired molecule(s) has to be present in abundant amounts (>4% of whole extract)
- A minimum of 7 grams as a sample of the product
Nice to have:
- Toxicological data for skin sensitization and genotoxicity
- If delivered in an isolated form 90%+ purity
Should not have:
- Norephedrine, Ephedrine, and Pseudoephedrin
Possible solution areas
- Biotech, Chemcial Suppliers, academic groups, and pharmaceutical companies
Previously attempted solutions (discarded)
- Raw extracts with full mixture of compounds
- Extracts from Ephedra Herba
Related Keywords
About Us
We are a company with global and multinational brands. Our business is highly R&D driven. We sell our products worldwide and target considerable market sizes with our innovations.
About Innovation Needs
Innovation Needs on Innoget are directly posted and managed by its members as well as evaluation of proposals. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.